We are guided by a strong moral compass and entrepreneurial spirit
Regeneron is valued and trusted for the innovative medicines we provide. Maintaining that trust requires each of us to always meet or exceed ethical standards. Our employees are at the center of our discoveries and the solutions we deliver to patients. We invest in their futures by building a high-engagement culture that recognizes their unique contributions and backgrounds and supports their development.
Ethical conduct builds trust in our company and is crucial to our business success. Our corporate philosophy of “Doing Well by Doing Good” inspires us and we pride ourselves on doing the right thing.
We take a collaborative approach to compliance and ensure that compliance principles and culture are embedded into each business unit. Our Compliance team always has a seat at the table and is an integral part of how our business is contemplated and conducted.
Our Compliance Program
Regeneron maintains written policies governing a wide variety of legal, regulatory and policy matters. All such policies are made available to employees on the corporate intranet. Our board of directors sets high standards for our colleagues, officers and directors, which are underpinned by sound corporate governance. Regeneron’s Compliance Program incorporates the seven fundamental key elements of an effective compliance program as defined by the OIG.
Written Policies and Procedures
We maintain written policies governing a wide variety of legal, regulatory and policy matters. All policies are made available to employees on the corporate intranet and are updated as required.
Melissa Lozner serves as the company’s chief compliance officer and chairs the Compliance Committee. The Compliance Committee is made up of senior leaders representing all the major functions in the company and meets at least quarterly to oversee the Compliance Program.
In addition, the Corporate Governance and Compliance Committee of the board of directors has oversight responsibility for all non-financial compliance matters. The chief compliance officer provides a report to the Corporate Governance and Compliance Committee on the status of the corporate compliance program at each board of directors meeting.
Effective training and education
Training resources include live training and online compliance education, as well as online access to policies. There are also new-hire and annual online training programs that support compliance education.
Effective lines of communication
Critical to the success of any compliance program is maintaining and fostering an environment where employees and others feel comfortable asking questions, raising concerns or offering ideas. Regeneron has an open-door policy that encourages employees to offer up ideas and solutions and allows employees to raise concerns to any supervisor, manager, human resources or the compliance department without fear of retaliation. Regeneron maintains an anonymous and confidential 24-hour hotline that provides individuals, whether employed by Regeneron or not, the means to raise concerns over any Regeneron activity that may be inconsistent with any law, regulation, company policy or our Code of Business Conduct and Ethics.
In addition to the confidential hotline, individuals may also make an anonymous report to our compliance website www.regeneron.ethicspoint.com. After entering the website, select File a Report to submit a question or concern.
These tools help promote an environment of compliance, integrity and trust amongst employees and our stakeholders.
Internal monitoring and auditing
Internal monitoring and auditing are integral parts of the Regeneron comprehensive Compliance Program. Effective monitoring and auditing aids in the detection and prevention of non-compliance. Regeneron has a dedicated team that conducts a variety of monitoring activities in an effort to ensure compliance with laws, regulations and policy.
Enforcement of standards through well-publicized disciplinary guidelines
Regeneron's Code of Business Conduct and Ethics includes a clear description of disciplinary standards, including the potential for termination as a result of non-compliance. Regeneron publishes its policies on progressive discipline and other disciplinary matters on its corporate intranet site.
Prompt response to detected problems through corrective actions
Any reports of suspected non-compliance that are raised to the attention of the Compliance Department are promptly investigated. Any corrective action will take place in a timely fashion and where necessary, matters shall be reported to relevant governmental authorities.
Regeneron’s reputation relies on the collective commitment of our colleagues to conduct business ethically, legally and in adherence to the high standards that we set for ourselves. Our ethical conduct builds trust in our company and is crucial to our business success.
The safety of our patients is our top priority and critical to delivering on our mission. Regeneron’s award-winning Industrial Operations and Product Supply (IOPS) organization has systems and training in place to ensure delivery of innovative and safe products. We comply with quality principles in our operations, manufacturing and distribution. This includes activities in our research laboratories, IOPS facilities and distribution centers. We comply with Good Laboratory Practices, Good Manufacturing Practices, Good Clinical Practice and Good Distribution Practices.
We take seriously our legal and ethical obligations to collect product technical complaints and adverse events related to our medications so that we can monitor their safe use throughout the product lifecycle. We are committed to our responsibility for timely reporting of safety information to the FDA and other regulatory authorities, in compliance with regulations and global expectations. In order to ensure full transparency to our expectations, we provide annual training on adverse event reporting for employees, contractors and suppliers.
Regeneron’s Rensselaer site was proud to be awarded the prestigious Shingo Prize in 2019 in recognition of its culture of continuous improvement and manufacturing excellence.
Laws, regulations and industry standards govern the advertising and promotion of our products. Our policies provide clear requirements for promotional materials and communications to employees, contingent workforce and vendors who communicate with the healthcare community. Customer-facing colleagues receive annual and extensive training regarding regulations and our policies.
We have several controls in place to ensure our clinical trial practices comply with laws and regulations and meet our high ethical standards.
Regeneron is a member of the Biotechnology Innovation Organization (BIO). We endorse BIO’s principles on the responsible sharing of truthful and non-misleading information about medicines with healthcare professionals and payers. We support data transparency that advances science and medicine, protects participant privacy and is in the best interest of individuals who use our products and providers who prescribe them. We are committed to sharing data from our clinical research and clinical trials in a responsible manner. View our Clinical Trial Disclosure and Data Transparency Statement.
We are committed to and abide by all ethical requirements related to animal welfare in research, teaching and testing. All research involving the use of live animals must be approved by the Regeneron Institutional Animal Care and Use Committee (IACUC), a requirement of U.S. federal and state laws. The IACUC has a key oversight role, including the review and approval of animal use activities and inspection of animal facilities. In addition, we comply with the Three Rs (Replacement, Reduction and Refinement), widely accepted ethical principles that are now embedded in the conduct of animal-based science in many countries around the world. Regeneron has earned accreditation from AAALAC International, a non-profit that assesses organizations that use animals in research, teaching or testing.
We meet or exceed all Environmental, Health, Safety (EHS) and Security regulations. We have an extensive range of programs, plans and procedures to ensure the safety of all people who come to work at Regeneron. These include:
- Hazard recognition and communication
- Risk evaluation and control elements
- Workplace design and engineering
- Regulatory compliance
- Emergency preparedness and business resiliency
- Employee training, education and engagement
We adhere to the standards set by local occupational health and safety regulatory bodies, such as the Occupational Safety and Health Administration (OSHA) and the Ireland Health and Safety Authority. We undertake routine site inspections and manage our leading EHS indicators to help reduce the risk of workplace accidents. We actively encourage colleagues to report potential hazards as a preventative measure.
We engage an independent assurance provider to conduct independent verification of select EHS data. Our latest Verification Statement can be found here.
Our COVID-19 Response to Worker Health and Safety
To uphold our robust safety systems and standards during the COVID-19 pandemic, we implemented changes in our business beginning in March 2020 to protect our employees, support appropriate health and safety protocols and ensure we could continue the important work being done across our sites to turn science into medicine.Read our policy on
Health & Safety
We are working towards our target to engage our top suppliers to gather and report relevant Scope 3 greenhouse gas (GHG) emissions. We see this as a natural evolution of our efforts to deepen our supplier relationships and crucial to co-creating successful solutions.
Supplier Governance and Compliance
As part of Regeneron’s compliance program, we hold our suppliers, contract manufacturers and business collaborators to our same high in-house standards, and we leverage existing policies to ensure adherence.
Our Vendor Code reflects the biopharmaceutical industry’s expectations for sustainable performance and is aligned both with Regeneron’s standards and with the Pharmaceutical Industry Principles for Responsible Supply Chain Management. We require that suppliers uphold the human rights of workers in accordance with applicable laws and treat them with dignity and respect.
In addition, we include clauses in all our contracts verifying that suppliers adhere to all local and international laws.
Our medicines are manufactured to the highest standards of quality, and we ensure that our supply chain maintains the same level of quality. Suppliers are routinely subject to quality audits, including written audits and on-site inspections. These audits, in concert with personal engagement of management and in-person meetings during routine business operations, would allow us to identify any violations of law or conflicts with our Compliance Program. Any supplier found to use forced labor or human trafficking would be terminated from the Regeneron supply chain.
We are committed to continually reviewing and revising our supplier arrangements to help ensure that our suppliers' products fully comply with all laws, including human rights laws. We are committed to continuing to provide effective training and education to our employees on all compliance matters, including training for our supply chain professionals regarding human trafficking and slavery.
Regeneron recognizes the value and importance of having a diverse supplier base reflective of our patients, customers, and the communities in which we live and work. We continue to engage small and diverse businesses as an important part of our sourcing and procurement activities by actively seeking firms for inclusion in the competitive bidding process and utilizing these businesses to the fullest extent possible.
Suppliers and the Environment
Sustainable materials selection is important to our business. We actively support suppliers that offer safe, environmentally responsible products. At our facilities, these can range from low-emissions carpet and low volatile organic compound paint to green cleaning products, environmentally friendly lab supplies and compostable tableware. If materials are not compostable, we try to select alternatives with recycled content.
Our operations during the COVID-19 pandemic
In response to the COVID-19 pandemic, we implemented changes in our business beginning in March 2020 to protect our employees and support appropriate health and safety protocols. For example, we have implemented work-from-home policies for a significant portion of our employees. For these remote employees, we provide ergonomic evaluations of at-home workstations, support information technology needs, and provide guidance for managers to ensure that employees remain connected and maintain physical, mental and emotional well-being. For our essential employees who remain onsite in our laboratories and manufacturing facilities, we provide PPE and require masks to be worn for those who are unvaccinated; we have also implemented increased physical distancing in workspaces and enhanced cleaning protocols. For any employee who contracts or is exposed to COVID-19, we provide full pay for their entire recovery and quarantine time.
Respecting privacy means protecting and properly handling the data with which we are entrusted. Regeneron’s privacy principles inform all aspects of our business. Our patients, colleagues, partners and other stakeholders trust Regeneron to protect the privacy of their personal data and we treat this responsibility with the utmost seriousness. This is especially important at a company on the cutting-edge of science and technology, because our business and the privacy landscape are dynamic. We have established Regeneron’s privacy philosophy to guide our people and our approach to scientific exploration and the development of our processes, medicines and services. It is our mission to advance science and research through the responsible handling of personal data.
Regeneron’s business — to discover, develop and deliver new medicines — requires long-term investments, not only in our labs and clinical trials but also in our employees, whose work and commitment fuel our success. Our investments take the form of comprehensive programs to attract and engage the best and brightest minds, foster a diverse and inclusive workplace, and develop and competitively reward employees.
The Regeneron Way
The Regeneron Way represents the values and behaviors that define who we are, what we stand for and how we work together.
If you think you’d be a good fit for Regeneron, visit our Careers website.
Lead with science
Science drives our business and passion drives our science. Whether you're doing science, supporting science or delivering science. It's what we do.
Take on big ideas
We take the long view and tackle the big ideas, the unsolvable problems, and the bottlenecks that get in the way. We pursue ideas with passion and courage, to make a real difference.
Make it happen
It may not always be easy, but we figure it out and get it done. We have little appetite for unnecessary bureaucracy that can get in the way of innovation or quality.
Be great together
While others talk about teamwork, we actually do it. When you work with smart, fun people, you bring out the best in each other and can do the extraordinary.
Do what's right
We do well by doing good. We act with integrity and pride ourselves on doing the right thing — by each other, our communities, our patients and the world around us.
We invest in a range of programs to attract, engage and reward the best and brightest minds, such as:
Our fellowship provides up to four years of formal postdoctoral training in a program directed by an award-winning educator.
Regeneron Prize for Creative Innovation
This annual award acknowledges and rewards talented PhD and postdoctoral students in biomedical research by granting over $150,000 in prize money. Interested in this prize?
We engage our colleagues from the moment they join us to foster new ideas, feed their collective curiosity and heighten productivity. Our annual employee survey and regular Regeneron pulse surveys help senior leaders and managers understand and act upon issues that are important to employees. We also share information about our company and our corporate strategy through quarterly business updates and events such as the Global Regeneron Forum, an all-employee meeting.
As our company grows rapidly, we have a responsibility to foster our culture of inclusion. We continue to embed business practices that promote diversity, equity and inclusion (DE&I) and leverage the advantages of our broad-based workforce.
We believe that grassroots, employee-led advocacy and interest groups offer a valuable platform to foster inclusion. These voluntary groups support and encourage like-minded colleagues to come together over shared interests. Regeneron supports these groups with company-sponsored time and resources. Our growing network includes groups such as our Black Employee Resource Group, ReLGBT Group, Women in Science and Engineering at Regeneron (WISER), Veterans at Regeneron and Humanity of Planet Earth Group for employees who are concerned about conservation and the environment.
We also believe senior-level oversight and employee involvement is crucial to shaping and advancing our formal, company-wide DE&I strategy, focused on fostering a culture of inclusion, increasing diverse representation and building equitable communities.
In April 2020, we proudly announced Regeneron’s global, 2025 responsibility goals, including a commitment to increase diversity in leadership and foster inclusion. With this goal in mind, we are accelerating our efforts to advance DE&I at Regeneron and in the communities we serve. Below is a selection of recent DE&I efforts and initiatives. We will continue to update this page with key progress milestones.
- Hired a Chief Diversity, Equity and Inclusion Officer to oversee and advance our strategy
- Established cross-functional DE&I Leadership Council to integrate our DE&I strategy across the organization
- Continued DE&I Listen & Learn sessions hosted by our leaders in order to better understand colleagues’ perspectives and experiences
- Rolled out mandatory inclusion trainings for all employees
- Provided colleagues with anti-racism resources to build awareness and understanding
- Implemented a new technology platform that helps to avoid any language that could inadvertently lead to potential gender bias in job descriptions
- Hired additional minority-focused recruiting firms to help attract diverse talent
- Accelerated efforts to enhance patient diversity in clinical trials, including establishing a Global Development leadership task force focused on this issue
- Launched a double matching gift campaign to support organizations dedicated to racial equality and social justice causes
Regeneron also continues to invest more than $3.1 million annually to support STEM equity and outreach programs in our communities.Learn more
One of the defining qualities of Regeneron is our openness to new ideas and continuous learning. We believe that we will only be successful if each individual can reach their full potential through continual learning and growth. Our Talent department promotes individual, leader, team and organizational development through a wide range of opportunities, including programs to support internal advancement, such as Elevate, our global manager capability-building program, and our Accelerate M.D. Program, designed to attract and develop top medical doctor (M.D.) talent to match our long-term pipeline growth.
Regeneron’s compensation, well-being, benefits and recognition philosophy focuses on supporting our colleagues by providing programs that are consistent with our unique culture and that acknowledge and support the diversity of our colleagues.
Our goal is to offer comprehensive plans and programs that meet our employees where they are today as well as where they want to be in the future.Learn more about our corporate benefits